Adding to the big score last week in Gap, Inc., GlaxoSmithKline has awarded its $1.4 billion U.S. media account to Omnicom Group’s PHD, beating out incumbent WPP’s MediaCom, Publicis Groupe’s Starcom and Havas’ MPG, according to AdAge. The move also makes up for a lot of lost ground when PHD lost its biggest client in Chrysler last year.
The GSK review covered planning and buying on consumer health-care and pharmaceutical businesses across all media. Prescription meds include Flonase, Valtrex and Zantac. Consumer products include Geritol, Nicorette, Nytol, Aquafresh, Alli, Super Poligrip and Tums.
RBR-TVBR observation: Looks like the strategic move in tapping Andrew McLean, former worldwide chief business development officer at WPP’s Group M as U.S. CEO in late October is turning out to be a good one.